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Background: The introduction of ophthalmodynamometric measurement of retinal venous pressure (RVP) now
permits the quantification, or at least an approximation, of the real pressure in the retinal veins.
Methods: We measured the RVP of healthy control subjects, patients with diabetes without diabetic retinopathy
(nonDR) and patients with diabetes and diabetic retinopathy (DR).
Results: The mean ± SD RVP for the control, nonDR and DR groups were 23.4 ± 7.33, 22.5 ± 5.78 and 37.7 ±
10.1 mmHg, respectively. In the diabetes patients with DR, the RVP was markedly and significantly increased, and
this result was significantly age dependent. RVP was not increased in the group of diabetes patients without DR. In
our tested population, diabetes had a minor influence on intraocular pressure.
Conclusion: Regardless of the cause, a marked increase in RVP in diabetes patients with DR is clinically relevant, as
it reduces perfusion pressure and increases transmural pressure. The reduced perfusion pressure contributes to
hypoxia, and the increased transmural pressure can facilitate retinal edema.
Diabetes is an increasing burden, and DR is one of its most severe complications. Strategies to recognize the risk for
DR and to develop personalized prevention and therapy therefore have major implications.
Trial registration: ClinicalTrials.gov ID: NCT01771835.
Keywords: Diabetic retinopathy (DR), Contact lens dynamometer (CLD), Ocular dynamic force (ODF), Retinal venous
pressure (RVP), Spontaneous venous pulsation, Ophthalmodynamometry, Personalized preventionOverview
Diabetic retinopathy (DR) is one of the leading causes of
blindness and visual impairment [1]. Nonproliferative
diabetic retinopathy (NPDR) often progresses to prolifer-
ative diabetic retinopathy (PDR), leading to severe visual
impairment.
Hyperglycemia and disease duration are the main risk
factors for both the incidence of NPDR and the conver-
sion to PDR [2]. However, other factors, such as sys-
temic arterial hypertension and dyslipidemia, also play a
crucial role [3,4].
Although diabetes mellitus (DM) is primarily an endocr-
inal disease, it also affects both the large and small vessels
in different parts of the body. Thus, diabetic complications* Correspondence: josef.flammer@usb.ch
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article, unless otherwise stated.are broadly classified as microvascular (retinopathy,
nephropathy and diabetic foot) and macrovascular
(heart disease, stroke and peripheral arterial disease)
complications [5].
In clinical settings, visual acuity, fundus examination,
optical coherence tomography (OCT) and fluorescein
angiography (FA) are routinely used to diagnose DR and
to monitor its progression. The retinal vascular system is
of particular interest for its early involvement and easy
accessibility. Several studies [6-8] have shown changes in
retinal vessel calibre and geometry, depending on dia-
betes duration and severity. However, retinal venous
pressure (RVP) has not been measured in patients with
diabetes thus far. Until recently, RVP was assumed to be
equal to intraocular pressure (IOP) [9], except under con-
ditions of increased cerebrospinal fluid pressure [10]. The
introduction of ophthalmodynamometric measurement ofed Central. This is an Open Access article distributed under the terms of the
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tory diagnostics.
Indeed, RVPs higher than IOPs have been observed
under several conditions [9,11,12]. On average, RVP is
elevated in patients with glaucoma [13,14] and in pa-
tients with retinal vein occlusion, to a greater extent in
the ischemic than in the nonischemic type [15].
An increase in RVP is of major relevance, as it de-
creases ocular perfusion pressure (the difference be-
tween central arterial pressure and central RVP) [9,14]
and increases transmural pressure, thus altering retinal
fluid homeostasis, which contributes to retinal edema.
We tested the hypotheses that a) RVP in DM patients
is different from normal controls and b) RVP in DM pa-
tients with and without retinopathy is different.
Methods
This study was carried out at the eye clinic at the Uni-
versity of Basel. The protocol was approved by the insti-
tutional ethics committee of the Medical Faculty of the
University of Basel. Each subject signed an informed
consent form before entering the study.
Subjects
We measured RVP a) in 254 eyes of 127 healthy control
subjects, b) in 40 eyes of 20 patients with diabetes with-
out diabetic retinopathy (nonDR) and c) in 54 eyes of 27
patients with diabetes and diabetic retinopathy (DRP).
We did not distinguish between proliferative and non-
proliferative DR, nor did we stage the severity of DR.
Most of the patients with diabetes were under the care
of internists at the Medical Faculty of the University of
Basel, and the blood sugar, blood pressure and lipids of
all the patients were well controlled.
The healthy controls were not on any medication. Ex-
clusion criteria for all three groups were any additional
eye disease; IOP values were not an exclusion criterion.
By chance, the lowest IOP value was less than 10 mmHg
and the highest value was more than 20 mmHg. The
subjects with IOP above 20 mmHg showed no signs of
glaucomatous optic neuropathy.
Test procedure
We had conducted a pilot study in which the RVP of all
the subjects was measured by two investigators, and the
averages of the resulting values were identical. For this
reason, the subjects included in the present study were
measured by one of the two investigators. Both eyes of
each subject were examined by a trained ophthalmolo-
gist to determine whether the subject qualified for inclu-
sion in the study. On the day of the study, IOP was
measured with a noncontact tonometer, after which the
pupils were dilated with Tropiphen® (tropicamide 5 mg
and phenylephrine 10 mg) eye drops. The central andhemiretinal veins on the disc surface were examined for
the presence of spontaneous pulsation. If pulsation was
observed, RVP was taken as equal to IOP. If no venous
pulsation was observed, RVP was measured after the ap-
plication of one drop of Alcaine® (proxymetacaine
hydrochloride 5 mg, Alcon) for topical anesthesia.Measurement of RVP
A contact lens dynamometer (CLD) was used to meas-
ure RVP. The FDA-approved CLD (Meditron GmbH,
Voelklingen, Germany) consists of a three-mirror Gold-
mann lens with a ring-shaped attachment containing
several precision sensors affixed to the rear. The sensors
continuously measure the force that the ophthalmologist
exerts on the eye by means of the contact lens. The CLD
is connected by a thin, flexible cable to a central unit ap-
proximately the size of a handheld calculator. A liquid
crystal display shows the delta pressure in millimetres
mercury, based on a calibration curve. The CLD, along
with a contact fluid (Methocel® 2%; CIBA Vision,
Germany), was placed on the cornea. Pressure was in-
creased until one of the segments of veins on or close to
the optic nerve head started to pulsate; the required
pressure is called ocular dynamic force (ODF). The RVP
was calculated as the sum of the ODF and the IOP [16].
If spontaneous venous pulsation was present, then the
ODF was said to be 0. The measurements were con-
ducted with a slit lamp biomicroscope (Haag-Streit) set
at × 16 magnification.
The term RVP used herein refers to the pressure in
the retinal veins close to the optic nerve and not gener-
ally in the retinal veins.Statistical analysis
Descriptive statistics of all the eyes are presented as
means and SD or counts and percentages for all study
groups. For age, the overall p-value was calculated using
analysis of variance (ANOVA) for independent groups.
For RVP and IOP, the overall p-values were calculated
using ANOVA based on linear mixed effects models. For
gender, p-value was based on the chi-square test. To as-
sess the differences in RVP and IOP among the study
groups, a linear mixed effects model was performed.
Mixed effects models are suitable techniques to account
for multiple correlated measurements within a subject.
The dependent variables were RVP or IOP, and the in-
dependent variables were study group, age and eye side.
Thus, the results were adjusted for age and eye side.
Subject ID is treated as a random factor to account for
potential correlation between the left and right eyes. The
results are presented as differences of the mean between
the two diabetes groups and the controls with corre-
sponding 95% confidence intervals and p-values.
Table 2 Descriptive statistics of age-matched data
Control NonDR DR p overall
N = 28 N = 40 N = 28
Age 58.5 (7.28) 55.3 (12.3) 58.6 (7.02) 0.55
IOP 14.9 (3.18) 15.3 (3.27) 15.9 (2.27) 0.319
RVP 25.2 (9.11) 22.5 (5.78) 33.8 (9.81) 0.0076
Gender 0.56
Female 14 (50%) 12 (30.0%) 10 (35.7%)
Male 14 (50%) 28 (70.0%) 18 (64.3%)
The retinal venous pressure (RVP) and intraocular pressure (IOP) are given in
millimetres mercury, and the age in years. They are expressed as the mean ±
SD for each study group.
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mated for each study group using a nested mixed effects
model and expressed as a regression slope.
The results are presented both without and with age
matching. To balance the age distribution between the
DR group and the controls, a propensity score matching
[17] was performed. To avoid further loss of sample size,
the nonDR group was not matched.
The dependence of RVP and IOP on age in the
matched and unmatched study groups is presented
graphically. A p-value <0.05 was considered significant.
All analyses were conducted using the R statistical soft-
ware package, version 2.15.1 [18]. Mixed effects models
were performed using the “nlme” package.
Results
The demographic description of the entire population
tested is provided in Table 1. The corresponding de-
scription of the age-matched population is provided in
Table 2. Considering the total population tested, IOP
tended to be slightly, but significantly, higher in the DR
group than in the control group and the nonDR group
(Table 1, Figure 1). RVP was clearly and significantly
higher in the DR group than in the control group and
the nonDR group (Table 3, Figure 2).
The frequency of spontaneous venous pulsation was
24% in the control group, 25% in the nonDR group and
0% in the DR group.
The patients with diabetes, particularly the ones with
DR, were significantly older (Table 1). Therefore, a sec-
ond analysis was performed on age-matched data. While
IOP was now not significantly different between the
groups anymore (Figure 3), RVP in these smaller groups
still remained significantly higher in the patients with
DR than in the control group and the nonDR group
(Table 2, Figure 4). In other words, RVP was higher in
the DR group compared to both the control and nonDR
groups (Table 3).
There was a highly significant dependence of RVP on
age for the nonmatched DR group (p < 0.001, slope =Table 1 Descriptive statistics of the entire study population
Control NonDR DR p overall
N = 254 N = 40 N = 54
Age 35.6 (13.4) 55.3 (12.3) 64.6 (9.09) <0.001
IOP 15.1 (3.01) 15.3 (3.27) 16.6 (2.67) <0.001
RVP 23.4 (7.33) 22.5 (5.78) 37.7 (10.1) <0.001
Gender 0.002
Female 154 (60.6%) 12 (30.0%) 16 (29.6%)
Male 100 (39.4%) 28 (70.0%) 38 (70.4%)
The retinal venous pressure (RVP) and intraocular pressure (IOP) are given in
millimetres mercury, and the age in years. They are expressed as the mean ±
SD for each study group.0.52, 0.26–0.78). All other matched and nonmatched
dependencies on age were not significant.Discussion
We tested the hypothesis that a) RVP in DM patients is
different from normal controls and b) RVP in DM pa-
tients with and without retinopathy is different.
In our tested population, the RVP of the group of dia-
betes patients without DR was not higher than that of
the control group (Table 2). The reason RVP was slightly
lower in the nonDR group remains unknown.
The RVP of the diabetes patients with DR was mark-
edly and significantly higher than that of the control
subjects and the diabetes patients without DR (Table 3).
This increase was significantly age dependent (Figure 2).Figure 1 Dependence of IOP on age for each study group
(unmatched data). Scatter plot of the IOP (mmHg) of each study
group (unmatched data) plotted versus the age (years) of the
subjects. Straight lines indicate regression slopes. Black circle control
group, red triangle nonDR group, green cross DR group. In all of the
groups, IOP had only a very slight tendency to increase with age.
Table 3 Mean differences in IOP and RVP between study









NonDR–control −1.72 0.18 2.09 0.85
DR–control −0.72 1.33 3.38 0.20
DR–nonDR −0.62 1.15 2.91 0.20
RVP
NonDR–control −6.33 −0.70 4.92 0.80
DR–control 0.30 6.37 12.44 0.040
DR–nonDR 2.37 7.07 11.77 0.004
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diabetes had a minor influence on IOP (Table 1).
Limitations of the study include lack of blood pressure
measurement, lack of differentiation among types of dia-
betes, unknown duration of diabetes and gender differ-
ences between the control and DR groups. Theoretically,
the higher RVP in the group of patients with DR might
be caused by different blood pressures in the groups.
However, this is very unlikely for the following reasons.
1) There is no indication in the literature that RVP is
blood pressure dependent [14,19]. 2) According to the
treating internist, the blood pressure of all of the dia-
betes patients was well controlled. The blood pressure
was measured in a timely fashion (within 10 days), and
the values never exceeded 150/90 mmHg. If we missedFigure 2 Dependence of RVP on age for each study group
(unmatched data). Scatter plot of the RVP (mmHg) of each study
group (unmatched data) plotted versus the age (years) of the subjects.
Straight lines indicate regression slopes. Black circle control group, red
triangle nonDR group, green cross DR group. RVP increased markedly
in patients with DR, but not in diabetes patients without DR.arterial hypertension, it was in the control group, where
we relied on information from the participants.
A number of questions remain open. We do not know
whether the increase in RVP with age reflects the dur-
ation of the disease or stage of severity. Furthermore, we
do not know the cause of the RVP increase. It could be
due to structural changes in the veins or the structures
around the veins [20], or it could reflect a dysregulation
of the retinal veins in the area of the optic nerve head or
lamina cribrosa [21].
Vascular and hemodynamic changes in the retina of
patients with DM are well known and have often been
reported [21]. While blood flow velocity in the retinal ar-
terioles and venules of DM patients with nonprolifera-
tive diabetic retinopathy is decreased [22], it is increased
patients with early DM without DR [23].
Diabetes also leads to variations in retinal vascular
calibre and in particular to a widening of retinal venular
calibre in patients with DR [24,25]. In these studies, RVP
was neither measured nor do their outcomes explain the
increase in RVP.
Future studies are required to confirm the increase in
RPV in patients with DR. The study design should con-
sider other parameters as well, such as blood pressure,
age, type and stage of diabetes and therapy.
Regardless of the cause, a marked increase in RVP in
diabetes patients with DR is clinically relevant, as it re-
duces perfusion pressure and increases transmural pres-
sure. The reduced perfusion pressure contributes toFigure 3 Dependence of IOP on age for each study group
(age-matched data). Scatter plot of the IOP (mmHg) of each study
group (matched data) plotted versus the age (years) of the subjects.
Regression line is not shown as the slope was not significantly different
from zero. Black circle control group, red triangle nonDR group, green
cross DR group.
Figure 4 Dependence of RVP on age for each study group
(age-matched data). Scatter plot of the RVP (mmHg) of each study
group (matched data) plotted versus the age (years) of the subjects.
Regression line is not shown as the slope was not significantly
different from zero. Black circle control group, red triangle nonDR
group, green cross DR group.
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tates retinal edema; hypoxia and edema are major com-
ponents of DR. While increased RVP contributes to
retinal hypoxia, such local hypoxia might increase RVP,
thus inducing a vicious circle [26].
Outlook
Clinical and scientific implications of our findings are at
present still open. Further studies are needed to establish
the relationship between RVP and different factors such
as blood pressure, duration of diabetes, or HB1c level.
We also must compare diabetes type 1 with diabetes
type 2 and NPDR with PDR. Of special interest is the
question whether an increased RVP predicts the devel-
opment of a future DR and whether it modifies the
course of an existing DR. We like to know the relation-
ship between RVP and retinal hemorrhages and whether
an increased RVP predisposes to a retinal vein occlusion.
Of special interest is the question whether we can re-
duce RVP and if so, whether this may help to prevent or
modify DR. If this will be the case, we will be one step
further in the direction of a predictive, preventive and
personalized medicine.
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